Fiche centre
Medical University of Vienna
Vienna — Austria
Essais liés7clinical trials
VilleViennalocalisation
PaysAustrialocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06091865
Essais cliniques associés
7| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Survodutide | Maladie rénale chronique | Phase 3 | NCT06077864 | A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT) | COMPLETED |
| Elective redo transcatheter aortic valve implantation (redo-TAVI) | Insuffisance cardiaque | À vérifier | NCT05601453 | The ReTAVI Prospective Observational Registry | RECRUITING |
| XEN1101 | Épilepsie | Phase 3 | NCT05716100 | A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) | RECRUITING |
| Odronextamab | Cancer | Phase 3 | NCT06091865 | OLYMPIA-3 — A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma | RECRUITING |
| ES2B-C001 | Cancer | Phase 1 | NCT06746688 | A First-in-human, Clinical Trial Assessing the Safety of ES2B-C001-S01 With or Without [Adjuvant] in Patients With HER2-expressing Metastatic Breast Cancer. | ACTIVE_NOT_RECRUITING |
| Erenumab | Migraine | À vérifier | NCT04628429 | CGRP-1 — CGRP Inhibition, Autonomic Function, and Migraine | RECRUITING |
| bright light therapy | SEP | NA | NCT04681586 | Bright Light Therapy as Possible Treatment Option for MS-Fatigue | UNKNOWN |